You searched for "macula"
Does paediatric rhegmatogenous retinal detachment (RRD) obey Lincoff’s rule (LR)?
3 February 2023
| Su Young
|
EYE - Vitreo-Retinal
|
Lincoff‘s rule, pediatric, retinal break, rhegmatogenous retinal detachment
This was a retrospective study where 98 paediatric patients with RRD were identified through surgery records. Forty case sheets with complete record of ocular examination and surgical findings were analysed. Visible or suspected preoperative retinal break identified using the LR...
Characteristics of bilateral retinal detachment
4 December 2023
| Sofia Rokerya
|
EYE - Vitreo-Retinal
|
Anatomic success rate, Bilateral retinal detachment, Buckle surgery, Fellow eye, Retinal symmetry, Vitrectomy
This was a retrospective study based at a tertiary centre which analysed the specific characteristics of bilateral Rhegmatogeous detachment, taken from the review notes of 300 patients (600 eyes) who had bilateral retinal detachment (RD) surgery between January 2005 and...
Pathological myopia: a trainer’s perceptive
3 April 2024
| Anitha Priya Arun Shankar, Adelehin Ijasan
|
EYE - Vitreo-Retinal
High myopia is defined as myopic refraction of greater than -6 dioptres with an axial length greater than 26.5mm, while pathological myopia is myopic refraction with posterior pole degeneration [1]. These degenerative changes can affect a young population and in...
Managing cataract surgery in a patient with diabetic maculopathy
A 56-year-old type 2 diabetic with previously treated bilateral diabetic maculopathy develops a cataract requiring surgery in the right eye. He has had grid laser previously, followed intermittently by intravitreal triamcinalone, Avastin and more recently Lucentis in both eyes. His...Management of proliferative diabetic retinopathy
1 August 2014
| Felicity Allen, Samantha S Mann
|
EYE - Vitreo-Retinal
Diabetic retinopathy is a major cause of blindness in the working-age population. Due to the worsening global epidemic of diabetes, the incidence of morbidity caused by the disease is set to increase [1]. The prevalence of diabetes in the UK...
21st Century retinal laser treatment in the anti-VEGF era
1 June 2017
| John Awad, Prasad Rao
|
EYE - Vitreo-Retinal
In today’s world, macular laser treatment has a vital role in the treatment of diabetic macular oedema (DMO). DMO is one of the most common causes of visual impairment. Despite expensive intravitreal treatment courses of anti-VEGF, many will agree that...
What not to miss in neuro-ophthalmology Part 2
1 August 2018
|
EYE - Neuro-ophthalmology
As mentioned previously there are several conditions in neuro-ophthalmology that should not be missed by the general ophthalmologist as well as ophthalmology trainees. We discussed in the first part some of these conditions including third cranial nerve palsies, giant cell...
The management of retinal vein occlusions: a summary
1 February 2015
| Amy-lee Shirodkar
|
EYE - Cataract, EYE - Refractive, EYE - Cornea, EYE - Imaging, EYE - Vitreo-Retinal, EYE - General
Retinal vein occlusions (RVO) are the most common cause of visual loss from retinal vascular disease second to diabetic retinopathy. Vision is lost due to ischaemia, macular oedema and / or haemorrhage which ultimately effects a patient’s quality of life...
Moorfields Education: Implementing a non-medical intravitreal injection service (19 May)
19 May 2023
This course is for clinicians working in an ophthalmic or medical retina setting, focusing on the treatment of age-related macular degeneration, retinal vein occlusion and diabetic oedema.
.
CHEC Bournemouth & CHEC Worthing Virtual CPD Open Evening
10 April 2025
CPD Topic: A Practical Guide To Macular OCT Analysis
CPD Speaker: Mahmoud Rabie
CPD Points: 2
Audience: OO’s, DO’s
Learning Outcomes: Clinical practice, professionalism
Aflibercept, bevacizumab or ranibizumab for DMO
1 August 2016
| Brian Ang
|
EYE - Vitreo-Retinal
This is a two-year randomised clinical trial of 660 patients with visual acuity impairment from diabetic macular oedema (DMO) who were randomised to monthly injections of 2.0mg aflibercept, 1.25 mg bevacizumab or 0.3mg ranibizumab. Focal or grid laser was performed...
Using OCT to screen and monitor Alzheimer’s disease
1 June 2016
| Claire Howard
|
EYE - Neuro-ophthalmology
|
Macular thickness, mild cognitive impairment, optical coherence tomography, subjective memory complaints
Alzheimer’s disease (AD) is a neurodegenerative illness characterised by progressive decline in cognitive function. AD is the main cause of dementia worldwide. Over recent years researchers have strived to find biomarkers to diagnose AD, particularly in the early stages of...
